{"id":"W2605079961","doi":"10.1200/jco.2012.30.15_suppl.e15118","title":"A phase II trial of neoadjuvant metformin in prostatic adenocarcinoma with serum and tissue biomarker evaluation.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital; University Health Network; University of Toronto; Ontario Institute for Cancer Research; Systems, Applications & Products in Data Processing (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metformin; Prostate cancer; Tolerability; Prostatectomy; Internal medicine; Adverse effect; Urology; Diabetes mellitus; Cancer; Prostate; Oncology; Insulin; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001861121,0.001491905,0.002328907,0.0005553886,0.000449308,0.001026628,0.001029876,0.001640921,0.005463357],"category_scores_gemma":[0.001110084,0.0007576055,0.001136795,0.0006450579,0.001020212,0.001026931,0.0005399876,0.002845186,0.001002277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008551478,"about_ca_system_score_gemma":0.001935015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007207003,"about_ca_topic_score_gemma":0.002299245,"domain_scores_codex":[0.9994177,0.0003291632,0.0000293098,0.00006805264,0.00005767671,0.00009813833],"domain_scores_gemma":[0.999051,0.0001247476,0.0002062424,0.00007136259,0.00005668432,0.0004898712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.873732,0.05359768,0.004004645,0.0007411487,0.0005557695,0.0001716521,0.0001252207,0.0009463227,0.01358725,0.0001690828,0.001954958,0.05041425],"study_design_scores_gemma":[0.5854893,0.4065529,0.004533531,0.00003018661,0.000145864,0.0001700749,0.00004074856,0.0005166465,0.001035571,0.0001135208,0.001354221,0.00001742228],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985689,0.002992808,0.0005724575,0.0007931541,0.0003353198,0.006149977,0.001073394,0.0001030557,0.002290688],"genre_scores_gemma":[0.9774082,0.002399073,0.002706407,0.001710522,0.0003866137,0.008767183,0.002727992,0.00003307113,0.003860853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005463357,"threshold_uncertainty_score":0.01827675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1194847573222735,"score_gpt":0.4796738490664636,"score_spread":0.3601890917441901,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}